LifeVantage recently launched its third European market in the past eight months with the addition of Ireland last week.
“The opening of Ireland is something that has been highly anticipated among many of our leaders in the UK in particular, and we expect it to be a productive asset in our larger European strategy,” said LifeVantage CEO Darren Jensen. “We’re excited to take this next step and grow our biohacking community in a part of the world that is key to our success.”
With select LifeVantage products having been offered in Ireland for approximately a year as part of the company’s Global Customer Acquisition Program, the country has already distinguished itself as a viable market.
“Ireland already has a solid base of customers who love our products and has proven itself a successful customer market in a relatively short period of time, so opening it up for distributor enrollments is the next natural progression,” said LifeVantage Chief Sales Officer Justin Rose. “We’re excited about Ireland’s prospects as our newest market.”
LifeVantage has operated in the United Kingdom, including Northern Ireland, since 2016 and has a European presence in Germany, Netherlands, Austria and Spain, in addition to Ireland.
The company anticipates further expansion in Europe to support growth in the region, including in Belgium, which is currently scheduled for launch next month. With the addition of Ireland, LifeVantage now serves 14 markets in North America, Europe, Australia, and Asia.